Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiretroviral Treatment Interruptions Predict Female Genital Shedding of Genotypically Resistant HIV-1 RNA

16 May 2012

Abstract excerpt

OBJECTIVES: Resistant viruses may emerge in the female genital tract during antiretroviral therapy (ART). Our objective was to identify predictors of drug-resistant HIV-1 RNA in genital secretions after initiation of nonnucleoside reverse transcriptase inhibitor-based therapy. DESIGN: We conducted a prospective cohort study with periodic evaluation of plasma and genital swab samples for HIV-1 RNA levels and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22592588
DOI: 10.1097/qai.0b013e31825bd703

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiretroviral Treatment Interruptions Predict Female Genital Shedding of Genotypically Resistant HIV-1 RNAPMID 22592588Read ↗

Determinants of HIV drug resistance mutations in plasma virus after treatment interruption.Semantic proximity Read ↗

HIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077.Semantic proximity Read ↗

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.Semantic proximity Read ↗

HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.Semantic proximity Read ↗

The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to < 400 copies/ml.Semantic proximity Read ↗

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.Semantic proximity Read ↗

Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations.Semantic proximity Read ↗

HIV-1 drug resistance in variants from the female genital tract and plasma.Semantic proximity Read ↗

Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.Semantic proximity Read ↗

Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.Semantic proximity Read ↗

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.Semantic proximity Read ↗

Genital tract HIV-1 RNA shedding among women with below detectable plasma viral loadSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.